Navigation Links
VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
Date:4/4/2013

SAN MARINO, Calif., April 4, 2013 /PRNewswire/ -- VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today positive results from stage two of its Pre-IND Phase I Study to test tolerability and toxicity in patients with advanced stage solid tumors.  The study, which is ongoing in patients with refractory or relapsed solid tumors, examines the safety and efficacy of hydroxychloroquine (HCQ), developed with VGLS' proprietary metabolic disruption technology (MDT), in combination with sorafenib (marketed as Nexavar®), which was co-developed by Bayer AG and Onyx Pharmaceuticals.

Haig Keledjian , CEO of VG Life Sciences, said, "We are happy to report we attained the safety endpoints we anticipated for our second cohort of patients.  Similar to the positive results we announced previously for our first patient cohort, no significant toxicities were observed at a higher dose of HCQ in combination with sorafenib.  We have begun enrolling patients into the next dosing cohort in this dose-escalation study and look forward to reporting those results in a timely fashion.  We anticipate patient recruitment to accelerate since opening up the enrollment criteria to include patients with breast, colon, lung, liver, pancreatic, and ovarian cancer, and look forward to an ultimate study completion date, from a safety standpoint, of third quarter 2013."

Dr. Tyler Curiel , gynecological oncologist at the Cancer Therapy & Research Center in San Antonio, TX, and principal investigator for the trial said, "Having successfully finished enrollment in cohort two, we have begun treating patients in the third cohort. The safety of our patients is pa
'/>"/>

SOURCE VG Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
2. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
3. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
4. BioDelivery Sciences to Present at the 25th Annual ROTH Conference
5. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
6. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
7. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
8. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
9. PointCross Life Sciences SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDAs Upcoming e-Data Submission Mandate
10. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
11. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... and MENLO PARK, Calif. , Aug. ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the ... The Company recently changed its fiscal year end to ... list its common stock on a national securities exchange ... statements as filed with the United States Securities Exchange ...
(Date:8/29/2014)... AMSTERDAM , August 29, 2014 ... invited to participate in the inaugural Tweetchat taking ... CPhI Worldwide , organised by UBM ... October 2014. #CPhIChat is a first of its ... media working across the supply chain, aimed to ...
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... pharmaceutical and biotechnology research and development outsourcing company, ... Chinese subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner"), acquired ... ("Charles River") Shanghai research facility. ...
... 24, 2011 Codexis, Inc. (Nasdaq: ... launch, its Codex® Screening Kits are in use ... pharmaceutical companies worldwide.  The announcement was made at ... here this week.   Codex® Screening ...
Cached Medicine Technology:ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 250 Pharma Companies Worldwide Now Use Codexis In Process Development 2
(Date:8/31/2014)... LabDoor.com tests the purity and label ... to their website, “We buy products in the same ... and online sites. No manufacturer-supplied samples are permitted at ... with LabDoor,” a recent study was performed on twenty ... the United States for Vitamin D3 content, heavy metal ...
(Date:8/31/2014)... In the wake of growing consumer concerns ... to require mandatory labeling of GMOs on food and ... that affect their own health and the health of ... measures to eliminate GMOs from dietary supplements, NutriGold has ... initiative with the objective of advancing the non-GMO ...
(Date:8/31/2014)... Twin to twin transfusion syndrome (TTTS) almost took ... were born, but an innovative fetal surgery at the SSM ... life. , Now, their parents David and Theresa Colp want to ... in St. Louis at the St. Louis Fetal Care Institute. They ... (6655 Delmar Blvd, St Louis, MO 63130) on Friday, Sept. 10 ...
(Date:8/31/2014)... Tickets for Brazil vs. Ecuador at MetLife Stadium ... This is great news for diehard soccer fans who would have ... the delight of soccer fans in the Tri-State area these two ... September 9th. , MetLife Stadium is the home field ... the National Football League. The venue opened in 2010 and has ...
(Date:8/31/2014)... 2014 Ticket Down is a dependable ... FL at the Sun Life Stadium in early September. Diehard ... The game on September 5th between Colombia and Brazil will likely ... last year between Brazil and Honduras at Sun Life Stadium brought ... 1987 and has also been the home of the Florida Marlins ...
Breaking Medicine News(10 mins):Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 2Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 3Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at the MetLife Stadium 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 3
... , CINCINNATI, July 23 LCA-Vision Inc. (Nasdaq: ... correction services under the Lasik Plus ((R)) brand, today announced ... CapStone Investments, 3rd Annual Small-Cap Investor Conference on Wednesday, July ... time). The conference is being held at Hyatt Regency ...
... , ... the dual console da Vinci, St. John,s aims to become regional training center , ... Springfield, Illinois (PRWEB) July 23, 2009 -- St. ... a dual console da Vinci surgical robot , and one of three hospitals in the ...
... ... physicians and sleep centers who work with member dentists to recommend and refer those patients ... oral appliances to CPAP . , ... (Vocus) July 23, 2009 -- In an effort to encourage more cooperation between sleep ...
... ... is one of just four states to deny any monetary award if injured party is ... ... needs to take prompt action and pass H813, a bill sponsored by Rep. John Blust ...
... Massachusetts General Hospital (MGH) physicians has developed a new general ... In the August issue of Anesthesiology , they describe ... altered version of an exiting anesthetic which does not ... anesthetics or prolonged suppression of adrenal gland activity, a problem ...
... ... in training should be working a 48-hour week. Aimed at protecting trainee doctors, health and ... move as a great opportunity, writes Robert Stiff MD Team24. , ... (PRWeb UK) July 22, 2009 -- The image ...
Cached Medicine News:Health News:St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery 2Health News:St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery 3Health News:Snoring Isn't Sexy, LLC Announces Commendation Program to Honor Sleep Physicians Who Work with Dentists to Manage Sleep Breathing Disorders 2Health News:Snoring Isn't Sexy, LLC Announces Commendation Program to Honor Sleep Physicians Who Work with Dentists to Manage Sleep Breathing Disorders 3Health News:Charlotte Attorney Calls on North Carolina Senate to Pass "Comparative Negligence" Bill in Order to Better Protect Injury Victims in State 2Health News:Mass. General team develops potentially safer general anesthetic 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 3
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
StarClose Clip Applier, (includes), Clip Applier, 6F Exchange Sheath, 6F Dilator, 0.038 50 cm J-Tip Guide Wire ...
... Delivering 3.5x, 4.5x and 5.5x magnification., ... Prismatic quality guarantees a true image. ... color rendition is ideal for intricate ... are treated with an anti-reflective coating ...
... and 3.0x magnification. The true benefit of ... while maintaining focal clarity is made possible ... The lightweight aluminum bar and individual pupillary ... and optimal focal alignment, eliminating headache and ...
Medicine Products: